search
Back to results

Neurostimulation for Cognitive Rehabilitation in Stroke (NeuroCog)

Primary Purpose

Stroke, Cognitive Impairment, Cerebral Infarction

Status
Unknown status
Phase
Phase 2
Locations
Brazil
Study Type
Interventional
Intervention
transcranial direct current stimulation
Sponsored by
Federal University of Paraíba
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Ischaemic chronic stroke
  • Mild/Moderate Cognitive impairment
  • Informed consent

Exclusion Criteria:

  • National Institute of Health Stroke Scale (NIHSS) ≥ 16 points
  • Severe cognitive comorbidities (dementia, depression)
  • transcranial direct current stimulation criteria: use of modulators of the Central Nervous System drugs; patients with implanted metallic or electronic devices; pacemaker; seizures; pregnancy;any other condition that might limit or interfere in the sensorimotor system

Sites / Locations

  • Suellen AndradeRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Active Comparator

Arm Label

dlPFC

CON

M1

Arm Description

Participants in the chronic post-stroke stage will receive active transcranial direct current stimulation in dorsolateral prefrontal cortex

Participants in the chronic post-stroke stage will receive active transcranial direct current stimulation in cingulo-opercular network

Participants in the chronic post-stroke stage will receive active transcranial direct current stimulation in motor primary cortex

Outcomes

Primary Outcome Measures

Executive Function measured by Dysexecutive Questionnaire (DEX)

Secondary Outcome Measures

Verbal Fluency (Semantic Fluency Test)
Response inhibition (Go-no-go Test)
Executive function (Wechsler Intelligence Scale for Adults)
Memory (Rey Auditory Verbal Learning)
Processing Speed (Letter Comparison and Pattern Comparison Tasks)

Full Information

First Posted
December 9, 2014
Last Updated
December 4, 2015
Sponsor
Federal University of Paraíba
Collaborators
Universidade Federal do Rio Grande do Norte
search

1. Study Identification

Unique Protocol Identification Number
NCT02315807
Brief Title
Neurostimulation for Cognitive Rehabilitation in Stroke
Acronym
NeuroCog
Official Title
Neurostimulation for Cognitive Enhancement After Stroke (NeuroCog)
Study Type
Interventional

2. Study Status

Record Verification Date
December 2015
Overall Recruitment Status
Unknown status
Study Start Date
December 2015 (undefined)
Primary Completion Date
March 2016 (Anticipated)
Study Completion Date
July 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federal University of Paraíba
Collaborators
Universidade Federal do Rio Grande do Norte

4. Oversight

5. Study Description

Brief Summary
Transcranial direct current stimulation has shown promising results in stroke patients. This study is a double blind, sham-controlled clinical trial aiming to compare the long-term effects of stimulation in two different cognitive regions after a stroke. Sixty patients who suffer from chronic strokes will be randomized into 1 of 3 groups: dorsolateral prefrontal cortex, cingulo-opercular network and motor primary cortex (control). Each group will receive transcranial direct current stimulation for 20 minutes for 10 consecutive working days (2 weeks). Patients will be assessed with a Dysexecutive Questionnaire, Semantic Fluency test, categorical verbal fluency and Go-no go tests, Wechsler Adult Intelligence Scale, Rey Auditory-Verbal Learning Test, Letter Comparison and Pattern Comparison Tasks at baseline, after their tenth stimulation session (week 2) and endpoint (week 4). Those who achieve clinical improvement with neurostimulation will be invited to receive treatment for 12 months as part of a follow-up study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke, Cognitive Impairment, Cerebral Infarction

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
dlPFC
Arm Type
Experimental
Arm Description
Participants in the chronic post-stroke stage will receive active transcranial direct current stimulation in dorsolateral prefrontal cortex
Arm Title
CON
Arm Type
Experimental
Arm Description
Participants in the chronic post-stroke stage will receive active transcranial direct current stimulation in cingulo-opercular network
Arm Title
M1
Arm Type
Active Comparator
Arm Description
Participants in the chronic post-stroke stage will receive active transcranial direct current stimulation in motor primary cortex
Intervention Type
Device
Intervention Name(s)
transcranial direct current stimulation
Other Intervention Name(s)
tdcs
Primary Outcome Measure Information:
Title
Executive Function measured by Dysexecutive Questionnaire (DEX)
Time Frame
Change for executive functions at 4 weeks
Secondary Outcome Measure Information:
Title
Verbal Fluency (Semantic Fluency Test)
Time Frame
[ Time Frame: Baseline, Week 2 and Week 4 ]
Title
Response inhibition (Go-no-go Test)
Time Frame
[ Time Frame: Baseline, Week 2 and Week 4 ]
Title
Executive function (Wechsler Intelligence Scale for Adults)
Time Frame
[ Time Frame: Baseline, Week 2 and Week 4 ]
Title
Memory (Rey Auditory Verbal Learning)
Time Frame
[ Time Frame: Baseline, Week 2 and Week 4 ]
Title
Processing Speed (Letter Comparison and Pattern Comparison Tasks)
Time Frame
[ Time Frame: Baseline, Week 2 and Week 4 ]

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Ischaemic chronic stroke Mild/Moderate Cognitive impairment Informed consent Exclusion Criteria: National Institute of Health Stroke Scale (NIHSS) ≥ 16 points Severe cognitive comorbidities (dementia, depression) transcranial direct current stimulation criteria: use of modulators of the Central Nervous System drugs; patients with implanted metallic or electronic devices; pacemaker; seizures; pregnancy;any other condition that might limit or interfere in the sensorimotor system
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Suellen Andrade
Email
suellenandrade@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Suellen Andrade, PhD
Organizational Affiliation
Federal University of Paraíba
Official's Role
Principal Investigator
Facility Information:
Facility Name
Suellen Andrade
City
João Pessoa
State/Province
PB
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Suellen Andrade

12. IPD Sharing Statement

Citations:
PubMed Identifier
26420269
Citation
Andrade SM, Fernandez-Calvo B, Boggio PS, de Oliveira EA, Gomes LF, Pinheiro Junior JE, Rodrigues RM, de Almeida NL, Moreira GM, Alves NT. Neurostimulation for cognitive rehabilitation in stroke (NeuroCog): study protocol for a randomized controlled trial. Trials. 2015 Sep 29;16:435. doi: 10.1186/s13063-015-0945-1.
Results Reference
derived

Learn more about this trial

Neurostimulation for Cognitive Rehabilitation in Stroke

We'll reach out to this number within 24 hrs